633
Views
26
CrossRef citations to date
0
Altmetric
Original Articles

Co-delivery of quercetin and caffeic-acid phenethyl ester by polymeric nanoparticles for improved antitumor efficacy in colon cancer cells

ORCID Icon & ORCID Icon
Pages 381-393 | Received 03 Feb 2021, Accepted 23 Jun 2021, Published online: 05 Jul 2021

References

  • Aghapour, F., et al., 2018. Quercetin conjugated with silica nanoparticles inhibits tumor growth in MCF-7 breast cancer cell lines. Biochemical and biophysical research communications, 500 (4), 860–865.
  • Amirsaadat, S., et al., 2021. Metformin and silibinin co-loaded PLGA-PEG nanoparticles for effective combination therapy against human breast cancer cells. Journal of drug delivery science and technology, 61, 102107.
  • Arasoglu, T., Derman, S., and Mansuroglu, B., 2016. Comparative evaluation of antibacterial activity of caffeic-acid phenethyl ester and PLGA nanoparticle formulation by different methods. Nanotechnology, 27 (2), 025103.
  • Arnold, M., et al., 2017. Global patterns and trends in colorectal cancer incidence and mortality. Gut, 66 (4), 683–691.
  • Batra, P., and Sharma, A.K., 2013. Anti-cancer potential of flavonoids: recent trends and future perspectives. 3 Biotech, 3 (6), 439–459.
  • Boedtkjer, E., and Pedersen, S.F., 2020. The acidic tumor microenvironment as a driver of cancer. Annual review of physiology, 82, 103–126.
  • Budisan, L., et al., 2019. Inhibitory effect of CAPE and kaempferol in colon cancer cell lines—possible implications in new therapeutic strategies. International journal of molecular sciences, 20 (5), 1199.
  • Chiang, E.P.I., et al., 2014. Caffeic-acid derivatives inhibit the growth of colon cancer: involvement of the PI3-K/Akt and AMPK signaling pathways. PLoS One, 9 (6), e99631.
  • Clayton, K.N., et al., 2016. Physical characterization of nanoparticle size and surface modification using particle scattering diffusometry. Biomicrofluidics, 10 (5), 054107.
  • Darwish, W.M.A., and Bayoumi, N.A., 2020. Gold nanorod-loaded (PLGA-PEG) nanocapsules as near-infrared controlled release model of anticancer therapeutics. Lasers in medical science, 35 (8), 1729–1740.
  • Du, J., Lane, L.A., and Nie, S., 2015. Stimuli-responsive nanoparticles for targeting the tumor microenvironment. Journal of controlled release: official journal of the controlled release society, 219, 205–214.
  • Durak, S., et al., 2020. Enhanced antibacterial and antiparasitic activity of multifunctional polymeric nanoparticles. Nanotechnology, 31 (17), 175705.
  • Duwa, R., et al., 2020. Cetuximab conjugated temozolomide-loaded poly (lactic-co-glycolic acid) nanoparticles for targeted nanomedicine in EGFR overexpressing cancer cells. Journal of drug delivery science and technology, 60, 101928.
  • Ersoz, M., et al., 2020. Quercetin-loaded nanoparticles enhance cytotoxicity and antioxidant activity on C6 glioma cells. Pharmaceutical development and technology, 25 (6), 757–766.
  • Ersoz, M., et al., 2019. Comparative evaluation of hesperetin loaded nanoparticles for anticancer activity against C6 glioma cancer cells.” Artificial cells, nanomedicine, and biotechnology, 47 (1), 319–329.
  • G. Nava-Arzaluz, M., et al., 2012. Single emulsion-solvent evaporation technique and modifications for the preparation of pharmaceutical polymeric nanoparticles. Recent patents on drug delivery & formulation, 6 (3), 209–223.
  • Granado-Serrano, A.B., et al., 2006. Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase/Akt and ERK pathways in a human hepatoma cell line (HepG2). Journal of Nutrition, 136 (11), 2715–2721.
  • Jan, R., and Chaudhry, G. S., 2019. Understanding apoptosis and apoptotic pathways targeted cancer therapeutics. Advanced pharmaceutical bulletin, 9 (2), 205–218.
  • Je, Y.Y., et al., 2005. Characterization of degradation behavior for PLGA in various PH condition by simple liquid chromatography method. Bio-Medical materials and engineering, 15 (4), 279–288.
  • Kabała-Dzik, A., et al., 2017. Comparison of two components of propolis: caffeic-acid (CA) and caffeic-acid phenethyl ester (CAPE) induce apoptosis and cell cycle arrest of breast cancer cells MDA-MB-231. Molecules, 22 (9), 1554.
  • Kang, B.K., et al., 2004. Controlled release of paclitaxel from microemulsion containing PLGA and evaluation of anti-tumor activity in vitro and in vivo. International journal of pharmaceutics, 286 (1–2), 147–156.
  • Kocak, G., Tuncer, C., and Bütün, V., 2017. PH-responsive polymers. Polymer chemistry, 8 (1), 144–176.
  • Lan, H., et al., 2017. Quercetin inhibits cell migration and invasion in human osteosarcoma cells. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology, 43 (2), 553–567.
  • Lee, H.Y., et al., 2015. Preparation of caffeic-acid phenethyl ester-incorporated nanoparticles and their biological activity. Journal of pharmaceutical sciences, 104 (1), 144–154.
  • Leigh Ackland, M., Van De Waarsenburg, S., and Jones, R., 2005. Synergistic antiproliferation action of the flavonols quercetin and kaempferol in cultured human cancer cell lines. In vivo, 19 (1), 69–76.
  • Lemoine, D., and Préat, V., 1998. Polymeric nanoparticles as delivery system for influenza virus glycoproteins. Journal of controlled release: official journal of the controlled release society, 54 (1), 15–27.
  • Li, J., et al., 2017. Synergistic inhibition of migration and invasion of breast cancer cells by dual docetaxel/quercetin-loaded nanoparticles via Akt/MMP-9 pathway. International journal of pharmaceutics, 523 (1), 300–309.
  • Livak, K.J., and Schmittgen, T.D., 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods (San Diego, Calif.), 25 (4), 402–408.
  • Miao, L., et al., 2014. Nanoparticles with precise ratiometric co-loading and co-delivery of gemcitabine monophosphate and cisplatin for treatment of bladder cancer. Advanced functional materials, 24 (42), 6601–6611.
  • Mu, L., and Feng, S.S., 2003. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol®): PLGA nanoparticles containing vitamin E TPGS. Journal of controlled release, 86 (1), 33–48.
  • Murtaza, G., et al., 2015. Possible molecular targets for therapeutic applications of caffeic-acid phenethyl ester in inflammation and cancer. Journal of food and drug analysis, 23 (1), 11–18.
  • Nam, J.S., et al., 2016. Application of bioactive quercetin in oncotherapy: from nutrition to nanomedicine. Molecules, 21 (1), 108.
  • Niedzwiecki, A., et al., 2016. Anticancer efficacy of polyphenols and their combinations. Nutrients, 8 (9), 552.
  • Pimple, S., et al., 2012. PLGA nanoparticles loaded with etoposide and quercetin dihydrate individually: in vitro cell line study to ensure advantage of combination therapy. Cancer nanotechnology, 3 (1-6), 25–36.
  • Pool, H., et al., 2012. Antioxidant effects of quercetin and catechin encapsulated into PLGA nanoparticles. Journal of nanomaterials, 2012, 1–12.
  • Qureshi, W.A., et al., 2016. Co-delivery of doxorubicin and quercetin via MPEG–PLGA copolymer assembly for synergistic anti-tumor efficacy and reducing cardio-toxicity. Science bulletin, 61 (21), 1689–1698.
  • Prabhuraj, R.S., et al., 2020. Dual drug delivery of curcumin and niclosamide using plga nanoparticles for improved therapeutic effect on breast cancer cells. Journal of polymer research, 27 (5), 1–13.
  • Ramalho, M.J., et al., 2019. Factorial design as a tool for the optimization of plga nanoparticles for the co-delivery of temozolomide and O6-benzylguanine. Pharmaceutics, 11 (8), 401.
  • Ren, K.W., et al., 2017. Quercetin nanoparticles display antitumor activity via proliferation inhibition and apoptosis induction in liver cancer cells. International journal of oncology, 50 (4), 1299–1311.
  • Sanderson, J.T., et al., 2013. Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic-acid derivatives in LNCaP human androgen-dependent prostate cancer cells. Bioorganic & medicinal chemistry, 21 (22), 7182–7193.
  • Sarkar, A., et al., 2016. Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells. Biochimica et biophysica acta, 1860 (10), 2065–2075.
  • Sghaier, M.B., et al., 2011. Flavonoids and sesquiterpenes from tecurium ramosissimum promote antiproliferation of human cancer cells and enhance antioxidant activity: a structure-activity relationship study. Environmental toxicology and pharmacology, 32 (3), 336–348.
  • Siegel, R.L., Miller, K.D., and Jemal, A., 2019. Cancer statistics, 2019. CA: A cancer journal for clinicians, 69 (1), 7–34.
  • Srivastava, N.S., and Srivastava, R.A.K., 2019. Curcumin and quercetin synergistically inhibit cancer cell proliferation in multiple cancer cells and modulate Wnt/β-catenin signaling and apoptotic pathways in A375 cells. Phytomedicine: international journal of phytotherapy and phytopharmacology, 52, 117–128.
  • Tang, H., et al., 2017. Anti-colon cancer effect of caffeic-acid p-nitro-phenethyl ester in vitro and in vivo and detection of its metabolites. Scientific reports, 7 (1), 1–11.
  • Twiddy, D., and Cain, K., 2007. Caspase-9 cleavage, do you need it? The biochemical journal, 405 (1), e1–e2.
  • Vauthier, C., and Bouchemal, K., 2009. Methods for the preparation and manufacture of polymeric nanoparticles. Pharmaceutical research, 26 (5), 1025–1058.
  • Wadhwa, R., et al., 2016. Molecular characterization and enhancement of anticancer activity of caffeic-acid phenethyl ester by γ cyclodextrin. Journal of cancer, 7 (13), 1755–1771.
  • Yang, L., et al., 2016. Quercetin-induced apoptosis of HT-29 colon cancer cells via inhibition of the Akt-CSN6-Myc signaling axis. Molecular medicine reports, 14 (5), 4559–4566.
  • Zhang, J., et al., 2014. Synergistic anti-tumor effects of combined gemcitabine and cisplatin nanoparticles in a stroma-rich bladder carcinoma model. Journal of controlled release: official journal of the controlled release society, 182 (1), 90–96.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.